Optimization of blood pressure measurement practices for pharmacodynamic analyses of tyrosine‐kinase inhibitors

Optimization of blood pressure measurement practices for pharmacodynamic analyses of tyrosine‐kinase inhibitors

Abstract Blood pressure measurements form a critical component of adverse event monitoring for tyrosine kinase inhibitors, but might also serve as a biomarker for dose titrations. This study explored the impact of various sources of within‐individual variation on blood pressure readings to improve m...

書誌詳細
主要な著者:	Maddalena Centanni, Abel Thijs, Ingrid Desar, Mats O. Karlsson, Lena E. Friberg
フォーマット:	論文
言語:	English
出版事項:	Wiley 2023-01-01
シリーズ:	Clinical and Translational Science
オンライン･アクセス:	https://doi.org/10.1111/cts.13423

類似資料

Model-Based Biomarker Selection for Dose Individualization of Tyrosine-Kinase Inhibitors
著者:: Maddalena Centanni, 等
出版事項: (2020-03-01)

Assessment of ibrutinib scheduling on leukocyte, lymph node size and blood pressure dynamics in chronic lymphocytic leukemia through pharmacokinetic‐pharmacodynamic models
著者:: Eman I. K. Ibrahim, 等
出版事項: (2023-09-01)

Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor
著者:: Sarah Waliany, MD, MS, 等
出版事項: (2019-09-01)

TYROSINE KINASE INHIBITORS AND INTERFERON
著者:: Maria Dimou, 等
出版事項: (2014-01-01)

TYROSINE KINASE INHIBITORS AND PREGNANCY
著者:: Elisabetta Abruzzese, 等
出版事項: (2014-04-01)

Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors Using Dried Blood Microsamples
著者:: Nick Verougstraete, 等
出版事項: (2022-03-01)

Receptor Tyrosine Kinases and Inhibitors in Lung Cancer
著者:: Evan Pisick, 等
出版事項: (2004-01-01)

Inhibition of c-Kit by tyrosine kinase inhibitors
著者:: Allison Galanis, 等
出版事項: (2015-03-01)

Tyrosine kinase inhibitor Tofacitinib. Safety issues
著者:: G. V. Lukina, 等
出版事項: (2015-12-01)

Tyrosine Kinase Inhibitors Target B Lymphocytes
著者:: Nikki Lyn Esnardo Upfold, 等
出版事項: (2023-02-01)

Spheroacanthocytes secondary to novel tyrosine kinase inhibitors
著者:: Michael Ashby, 等
出版事項: (2020-11-01)

Second-generation inhibitors of Bruton tyrosine kinase
著者:: Jingjing Wu, 等
出版事項: (2016-09-01)

Targeting tumour microenvironment by tyrosine kinase inhibitor
著者:: Hor-Yue Tan, 等
出版事項: (2018-02-01)

Mechanisms of resistance to EGFR tyrosine kinase inhibitors
著者:: Lihua Huang, 等
出版事項: (2015-09-01)

Mechanisms of acquired resistance to tyrosine kinase inhibitors
著者:: Yi-fan Chen, 等
出版事項: (2011-12-01)

Tyrosine Kinase Inhibitors in Pulmonary Vascular Disease
著者:: John J. Ryan, MD
出版事項: (2016-12-01)

Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer
著者:: Yu Yao, 等
出版事項: (2023-01-01)

The two facets of receptor tyrosine kinase in cardiovascular calcification—can tyrosine kinase inhibitors benefit cardiovascular system?
著者:: Ainun Nizar Masbuchin, 等
出版事項: (2022-09-01)

Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
著者:: Xu H, 等
出版事項: (2019-07-01)

Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma
著者:: Huang JT, 等
出版事項: (2022-11-01)

Novel Approaches for Efficient Delivery of Tyrosine Kinase Inhibitors
著者:: Zahra Moradpour, 等
出版事項: (2019-01-01)

Advances in MET tyrosine kinase inhibitors in gastric cancer
著者:: Yifan Zhang, 等
出版事項: (2024-06-01)

Mechanism and treatment of diarrhea associated with tyrosine kinase inhibitors
著者:: Jiangnan Liu, 等
出版事項: (2024-03-01)

The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström’s Macroglobulinemia
著者:: Obada Ababneh, 等
出版事項: (2022-05-01)

Tyrosine kinase inhibitors in osteosarcoma: Adapting treatment strategiesa
著者:: Ahmad Assi, 等
出版事項: (2023-12-01)

Structural Insight and Development of EGFR Tyrosine Kinase Inhibitors
著者:: Tasia Amelia, 等
出版事項: (2022-01-01)

Flavonoids as receptor tyrosine kinase inhibitors in lung cancer
著者:: Sareshma Sudhesh Dev, 等
出版事項: (2023-11-01)

Tyrosine kinase inhibitors, ionic currents, and cardiac arrhythmia
著者:: Chi-Hao Hu, 等
出版事項: (2023-07-01)

Pulmonary hypertension with dasatinib and other tyrosine kinase inhibitors
著者:: Ashraf El-Dabh, 等
出版事項: (2019-07-01)

Advances in studies of tyrosine kinase inhibitors and their acquired resistance
著者:: Qinlian Jiao, 等
出版事項: (2018-02-01)

Tyrosine Kinase Inhibitors - Induced Cutaneous Leukocytoclastic Vasculitis
著者:: Diogo Alpuim Costa, 等
出版事項: (2018-05-01)

Tyrosine Kinase Inhibitor Induced Isolated Pericardial Effusion
著者:: Vineet Agrawal, 等
出版事項: (2015-02-01)

Acquired Resistance Mechanism for MET Tyrosine Kinase Inhibitor
著者:: Toshio Fujino, MD, 等
出版事項: (2021-03-01)

Exploring receptor tyrosine kinases-inhibitors in Cancer treatments
著者:: D. Samuel Metibemu, 等
出版事項: (2019-12-01)

The Lysosomal Sequestration of Tyrosine Kinase Inhibitors and Drug Resistance
著者:: Eliska Ruzickova, 等
出版事項: (2019-10-01)

Small molecule tyrosine kinase inhibitors in pancreatic cancer
著者:: Sachin Gupta, 等
出版事項: (2008-10-01)

Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma
著者:: Domenico Ribatti
出版事項: (2010-04-01)

A Review on Newer Tyrosine Kinase Inhibitors and their Uses
著者:: NITHU M KUMAR, 等
出版事項: (2018-08-01)

Resistant Mechanism and Treatment Strategy of Tyrosine Kinase Inhibitors
著者:: Jianbing QIAO, 等
出版事項: (2011-10-01)

Editorial: New Insights on Bruton’s Tyrosine Kinase Inhibitors
著者:: C. I. Edvard Smith, 等
出版事項: (2021-11-01)